S Dzienis-Straczkowska, M Straczkowski, M … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS— Obese-IGT subjects were more insulin resistant in comparison with
obese-NGT and control-NGT groups; obese-NGT subjects were more insulin resistant
than control-NGT. Plasma sTNFR1 and sTNFR2 were markedly higher in both ... Cited by 42 - Related articles - BL Direct - All 5 versions
M Straczkowski, I Kowalska, A Stepien, S … - Diabetes Care, 2002 - Am Diabetes Assoc OBJECTIVE—Tumor necrosis factor-α (TNF-α) is one of the proposed mediators
of insulin resistance, upregulated in human obesity. Insulin resistance,
however, might precede the development of obesity, especially in subjects ... Cited by 40 - Related articles - BL Direct - All 6 versions
- ►eje.org [PDF] M Straczkowski, I Kowalska, S Dzienis- … - European journal of endocrinology, 2001 - eje.org Objective: Tumor necrosis factor-a (TNFa) plays an important role in the
pathogenesis of insulin resistance and type 2 diabetes. Plasma levels of the
soluble (s) fractions of TNFa receptors, especially sTNFR2, are good ... Cited by 57 - Related articles - BL Direct - All 8 versions
JM Fernández-Real, M Broch, W Ricart, R … - DIABETES-NEW YORK-, 1998 - Am Diabetes Assoc Recent studies have shown that the tumor necrosis fac- tor (TNF) system is
implicated in the insulin resistance of human obesity. Plasma concentrations of
the soluble fraction of the TNF receptors 1 and 2 (sTNFR1 and sTNFR2) are ... Cited by 153 - Related articles - BL Direct - All 4 versions
M Straczkowski, I Kowalska, A Nikolajuk, A … - Cardiovascular Diabetology, 2006 - ukpmc.ac.uk Tumor necrosis factor-α (TNFα) is a mediator of insulin resistance. Plasma
levels of soluble TNFα receptors (sTNFR1 and sTNFR2) probably reflect paracrine
action of the cytokine. TNFα is also a regulator of lipid metabolism, ... Related articles
JM Fernández-Real, P Botas-Cervero, B … - Clinical Immunology, 2006 - Elsevier In a previous study, we identified a biologically active form of tumor necrosis
factor-alpha receptor 2 (sTNFR2) produced by differential splicing (DS-TNFR2)
which antagonized TNF-α biological activity. Obesity, insulin resistance ... Cited by 4 - Related articles - All 3 versions
AV Benjafield, XL Wang, BJ Morris - Journal of Molecular Medicine, 2001 - Springer Abstract Tumor necrosis factor (TNF)-α has been impli- cated in
pathophysiological processes in coronary artery disease (CAD). TNF receptor 2 is
of particular interest in mediating such effects. The gene for this ... Cited by 49 - Related articles - BL Direct - All 3 versions
JP Bastard, C Jardel, E Bruckert, H Vidal, B … - Diabetes Obesity and Metabolism, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 25 - Related articles - BL Direct - All 4 versions
JM Fernandez-Real, A Molina, M Broch, W … - DIABETES-NEW YORK-, 1999 - Am Diabetes Assoc Myotonic dystrophy (MyD) is a multisystem autosomal dominant disorder associated
with progressive muscle wasting and weakness. The striking metabolic abnor-
mality in MyD is insulin resistance. The mechanism by which target tissues ... Cited by 55 - Related articles - BL Direct - All 4 versions
- ►eje.org JM Fernandez-Real, M Straczkowski, B Lainez, … - European journal of endocrinology, 2006 - eje.org Results: Real time PCR confirmed gene expression of DS-TNFR2 in monocytes from
healthy subjects. A significant and positive association was found between serum
DS-TNFR2 concentration and insulin sensitivity (P = 0.032, n = 76). This ... Cited by 3 - Related articles - BL Direct - All 9 versions
